Cargando…
Molecular sovereignties: patients, genomes, and the enduring biocoloniality of intellectual property
Monoclonal antibodies are revolutionizing cancer treatments, but come at an increasingly problematic price for health services worldwide. This leads to pressing demands for access, as in the case of Kadcyla. In 2015, patients in the United Kingdom invoked the sovereign rights of the Crown in order t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Palgrave Macmillan UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254056/ https://www.ncbi.nlm.nih.gov/pubmed/34249139 http://dx.doi.org/10.1057/s41292-021-00237-5 |